She was born in San Vicent del Raspeig, Alicante, in 1965 and she holds a PhD in Biochemistry and Molecular Biology. She was a pupil of Margarita Salas, a pioneering researcher in those fields and she has also worked with Carol W. Greider, who received the Nobel Prize in Medicine in 2009, in the prestigious Cold Spring Harbor Laboratory of New York. Her research has mainly focused on telomeres and telomerase, which are closely linked to the ageing process and the diseases associated with it. As for her professional career in Spain, she joined the Spanish National Research Council (CSIC) and led a team of researchers at the Department of Immunology and Oncology of the National Centre for Biotechnology. She started working for the Spanish National Cancer Research Centre (CNIO), which she currently heads. She has received national and international awards, such as the Ramón y Cajal National Award for Research or the European Molecular Biology Organization (EMBO) Gold Medal for best European researcher under the age of 40.

He holds a PhD in Biology and he is a Professor of Genetics at the University of Valencia. His research focuses on molecular genetics and genomic applied to medicine. He is known for his outreach work. He is the author of more than 50 research papers on his field of expertise, including three articles published by the prestigious journal Nature. As a scientific entrepreneur, he is a founding partner of the company Sistemas Genómicos (Genomic Systems), Valentia BioPharma and the Genomic Medicine Institute, among others.

Graduated in Biomedical Sciences at the University of Navarra, Manuel Corpas focused in the human genome since the very beginning of his career. He has worked in the National Institute of Bioinformatics and the Sanger Institute of genome analysis. Besides, he has lead a research about animal and plant’s genome in The Genome Analysis Center. Last 2016 he joined Repositive, a start-up specialized in sharing and storing genomes of different types. The aim is expanding and disseminating the expertise of this field of science. Now he is the CEO/Founder of Cambridge Precision Medicine.